Table 1 Baseline demographic and clinical characteristics of participants N = 158
From: Patients’ confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC)
Variable | All patients with DSE (n = 158) | SABR (n = 73) | Surgery (n = 85) |
|---|---|---|---|
Treatment (surgery, %) | 85 (53.8) | ||
Gender (male, %) | 69 (43.6) | 26 (35.6) | 43 (50.5) |
Age (years, SD) | 72.4 (8.6) | 74.5 (9.3) | 70.5 (7.5) |
Comorbidity (yes, %) | 135 (85.4) | 67 (91.7) | 68 (80) |
FEV1% (SD) | 83.5 (25.1) | 75.5 (27.4) | 89.2 (21.8) |
DLCO% (SD) | 77.6 (22.2) | 69.6 (22.8) | 83.5 (19.9) |
Currently smoking (n, %) | 34 (22.6%) | 19 (27.1) | 15 (18.7) |
PS > 1 (n, %) | 104 (62.4) | 39 (53.4) | 15 (17.6) |
DSE (Mean, SD) | 81.7 (23) | 79.5 (23) | 83.6 (22.9) |